Search - tctmd.com

Displaying 561 - 580 of 1464

Sort: Relevancy | Date

YOUNG-MI: Quick EF Recovery Key to Cutting Deaths in Those Under 50

News Daily News

YOUNG-MI: Quick EF Recovery Key to Cutting Deaths in Those Under 50

June 04, 2020

Carotid Endarterectomy Little Help in Asymptomatic Patients: VA Study

News Daily News

Carotid Endarterectomy Little Help in Asymptomatic Patients: VA Study

June 04, 2020

Swedish Data ‘Corroborate’ FFR’s Survival Benefit Seen in RCTs

News Daily News

Swedish Data ‘Corroborate’ FFR’s Survival Benefit Seen in RCTs

June 03, 2020

COVID-19: TCTMD’s Daily Dispatch for June

News Daily News

COVID-19: TCTMD’s Daily Dispatch for June

June 01, 2020

New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD

News Daily News

New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD

Michael O'Riordan

June 01, 2020

Dose of Reality? Hydroxychloroquine and Chloroquine Again Disappoint in COVID-19

News Daily News

Dose of Reality? Hydroxychloroquine and Chloroquine Again Disappoint in COVID-19

Michael O'Riordan

May 26, 2020

Hydroxychloroquine: No Help, Clear Harm in COVID-19 RCT and Cohort Studies

News Features

Hydroxychloroquine: No Help, Clear Harm in COVID-19 RCT and Cohort Studies

May 20, 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

News Conference News SCAI 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

May 15, 2020

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

News Daily News

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Michael O'Riordan

May 15, 2020

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Michael O'Riordan

May 12, 2020

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

News Daily News

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

May 06, 2020

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

News Daily News

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Michael O'Riordan

May 04, 2020

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

Obesity and COVID-19: Theories and Blame Fill the Scientific Void

News Features

Obesity and COVID-19: Theories and Blame Fill the Scientific Void

April 21, 2020

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

News Conference News ACC 2020

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Yael L. Maxwell

April 06, 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

News Conference News ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

April 02, 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.